Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival
- PMID: 22576210
- DOI: 10.1158/2159-8290.CD-11-0234
Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival
Abstract
Alterations in metabolic activity contribute to the proliferation and survival of cancer cells. We investigated the effect of siRNA-mediated gene silencing of 222 metabolic enzymes, transporters, and regulators on the survival of 3 metastatic prostate cancer cell lines and a nonmalignant prostate epithelial cell line. This approach revealed significant complexity in the metabolic requirements of prostate cancer cells and identified several genes selectively required for their survival. Among these genes was 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4), an isoform of phosphofructokinase 2 (PFK2). We show that PFKFB4 is required to balance glycolytic activity and antioxidant production to maintain cellular redox balance in prostate cancer cells. Depletion of PFKFB4 inhibited tumor growth in a xenograft model, indicating that it is required under physiologic nutrient levels. PFKFB4 mRNA expression was also found to be greater in metastatic prostate cancer compared with primary tumors. Taken together, these results indicate that PFKFB4 is a potential target for the development of antineoplastic agents.
Significance: Cancer cells undergo several changes in their metabolism that promote growth and survival. Using an unbiased functional screen, we found that the glycolytic enzyme PFKFB4 is essential for prostate cancer cell survival by maintaining the balance between the use of glucose for energy generation and the synthesis of antioxidants. Targeting PFKFB4 may therefore present new therapeutic opportunities.
Comment in
-
Metabolism: Unravelling metabolic dependencies.Nat Rev Cancer. 2012 May 24;12(5):321. doi: 10.1038/nrc3273. Nat Rev Cancer. 2012. PMID: 22525575 No abstract available.
-
Cancer cell metabolism: there is no ROS for the weary.Cancer Discov. 2012 Apr;2(4):304-7. doi: 10.1158/2159-8290.CD-12-0069. Cancer Discov. 2012. PMID: 22576206
Similar articles
-
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.FEBS Lett. 2004 Oct 8;576(1-2):14-20. doi: 10.1016/j.febslet.2004.08.053. FEBS Lett. 2004. PMID: 15474002
-
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.Oncogene. 2017 Jun 8;36(23):3287-3299. doi: 10.1038/onc.2016.477. Epub 2017 Jan 16. Oncogene. 2017. PMID: 28092678
-
Cancer cell metabolism: there is no ROS for the weary.Cancer Discov. 2012 Apr;2(4):304-7. doi: 10.1158/2159-8290.CD-12-0069. Cancer Discov. 2012. PMID: 22576206
-
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.Mol Metab. 2019 Feb;20:1-13. doi: 10.1016/j.molmet.2018.11.013. Epub 2018 Dec 5. Mol Metab. 2019. PMID: 30553771 Free PMC article. Review.
-
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.Exp Mol Pathol. 2009 Jun;86(3):174-9. doi: 10.1016/j.yexmp.2009.01.003. Epub 2009 Jan 14. Exp Mol Pathol. 2009. PMID: 19454274 Review.
Cited by
-
Integrated aerobic exercise with LDE-docetaxel treatment: a novel approach to combat prostate cancer progression.Sci Rep. 2024 Apr 26;14(1):9626. doi: 10.1038/s41598-024-60138-y. Sci Rep. 2024. PMID: 38671015 Free PMC article.
-
Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1-mediated lipid metabolism.Clin Transl Med. 2024 Feb;14(2):e1587. doi: 10.1002/ctm2.1587. Clin Transl Med. 2024. PMID: 38372484 Free PMC article.
-
Metabolomic biomarkers of habitual B vitamin intakes unveil novel differentially methylated positions in the human epigenome.Clin Epigenetics. 2023 Oct 19;15(1):166. doi: 10.1186/s13148-023-01578-7. Clin Epigenetics. 2023. PMID: 37858220 Free PMC article.
-
Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening.Sci Rep. 2023 Jun 3;13(1):9043. doi: 10.1038/s41598-023-35950-7. Sci Rep. 2023. PMID: 37270558 Free PMC article.
-
Obesity and prostate cancer - microenvironmental roles of adipose tissue.Nat Rev Urol. 2023 Oct;20(10):579-596. doi: 10.1038/s41585-023-00764-9. Epub 2023 May 17. Nat Rev Urol. 2023. PMID: 37198266 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical